A股異動 | 東方材料跌停 擬收購鼎橋遭華為反對
格隆匯4月10日丨東方材料(603110.SH)跌停,報40.02元,總市值81億元。東方材料9日公吿宣佈擬通過定增募資,收購通信巨頭諾基亞所持有的TD TECH(鼎橋通信)51%股權,交易對價為21.216億元。收購完成後,鼎橋將成為上市公司的控股子公司。東方材料還在預案中提示,未來若鼎橋與華為的合作關係發生變化,可能對鼎橋業務發展產生不利影響。對此,上交所4月9日向東方材料下發監管工作函,就公司非公開發行事項提出監管要求。值得一提的是,9日深夜,華為官方發佈聲明稱,公司沒有任何意願及可能與新東方新材料合資運營鼎橋。華為方面表示,與諾基亞運營鼎橋是基於雙方的戰略合作與雙方技術實力、全球的銷售與服務能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.